{"title":"Assessing diagnostic, vaccine and therapeutic potential of selected Trichinella proteins","authors":"Anna Stachyra , Justyna Bień-Kalinowska","doi":"10.1016/j.fawpar.2025.e00283","DOIUrl":null,"url":null,"abstract":"<div><div>Trichinellosis is an important zoonotic parasitosis caused by nematodes of the genus <em>Trichinella</em>. In humans, <em>Trichinella</em> infection occurs through the ingestion of raw or semi-cooked meat of animals infected with <em>Trichinella spp.</em> larvae, as the causative agent. Over the past decade, technological developments have enabled great achievements in the study of the genome, secretome and proteome of <em>Trichinella</em>. These achievements provide knowledge to screen, identify, and compare the proteins and antigens involved in the host-parasite communication and interactions with the host's immune system and thus constituting diagnostic, vaccine, or therapeutic targets. Much attention has been focused on identifying and characterizing proteins from different <em>Trichinella</em> stages to find molecules useful for serodiagnosis and vaccine development. This review presents a number of recombinant proteins examined as candidates for diagnosis of <em>Trichinella</em> infection. However, antigens suitable for improved early diagnosis or detection are not yet available. Identification of potential vaccine candidates against trichinellosis remains a significant challenge. Various recombinant protein vaccines have been reviewed to improve the protective effect against <em>Trichinella</em> infection in mice, rat or swine models. A considerable amount of research has investigated the immunomodulatory potential of <em>Trichinella</em> proteins. The application of total ES products as well as individual components in recombinant form, showed that they exert strong immunomodulatory effects and can act prophylactically or therapeutically in animal models of autoimmune diseases. This paper provides an overview and summary of recent achievements in the field of <em>Trichinella</em> recombinant proteins, emphasizing their potential application to diagnosis, vaccination, and modulation of allergy and oncogenesis.</div></div>","PeriodicalId":37941,"journal":{"name":"Food and Waterborne Parasitology","volume":"40 ","pages":"Article e00283"},"PeriodicalIF":3.1000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Food and Waterborne Parasitology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2405676625000307","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PARASITOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Trichinellosis is an important zoonotic parasitosis caused by nematodes of the genus Trichinella. In humans, Trichinella infection occurs through the ingestion of raw or semi-cooked meat of animals infected with Trichinella spp. larvae, as the causative agent. Over the past decade, technological developments have enabled great achievements in the study of the genome, secretome and proteome of Trichinella. These achievements provide knowledge to screen, identify, and compare the proteins and antigens involved in the host-parasite communication and interactions with the host's immune system and thus constituting diagnostic, vaccine, or therapeutic targets. Much attention has been focused on identifying and characterizing proteins from different Trichinella stages to find molecules useful for serodiagnosis and vaccine development. This review presents a number of recombinant proteins examined as candidates for diagnosis of Trichinella infection. However, antigens suitable for improved early diagnosis or detection are not yet available. Identification of potential vaccine candidates against trichinellosis remains a significant challenge. Various recombinant protein vaccines have been reviewed to improve the protective effect against Trichinella infection in mice, rat or swine models. A considerable amount of research has investigated the immunomodulatory potential of Trichinella proteins. The application of total ES products as well as individual components in recombinant form, showed that they exert strong immunomodulatory effects and can act prophylactically or therapeutically in animal models of autoimmune diseases. This paper provides an overview and summary of recent achievements in the field of Trichinella recombinant proteins, emphasizing their potential application to diagnosis, vaccination, and modulation of allergy and oncogenesis.
期刊介绍:
Food and Waterborne Parasitology publishes high quality papers containing original research findings, investigative reports, and scientific proceedings on parasites which are transmitted to humans via the consumption of food or water. The relevant parasites include protozoa, nematodes, cestodes and trematodes which are transmitted by food or water and capable of infecting humans. Pertinent food includes products of animal or plant origin which are domestic or wild, and consumed by humans. Animals and plants from both terrestrial and aquatic sources are included, as well as studies related to potable and other types of water which serve to harbor, perpetuate or disseminate food and waterborne parasites. Studies dealing with prevalence, transmission, epidemiology, risk assessment and mitigation, including control measures and test methodologies for parasites in food and water are of particular interest. Evidence of the emergence of such parasites and interactions among domestic animals, wildlife and humans are of interest. The impact of parasites on the health and welfare of humans is viewed as very important and within scope of the journal. Manuscripts with scientifically generated information on associations between food and waterborne parasitic diseases and lifestyle, culture and economies are also welcome. Studies involving animal experiments must meet the International Guiding Principles for Biomedical Research Involving Animals as issued by the Council for International Organizations of Medical Sciences.